Home
About
Overview
Sharing Data
ORCID
Help
History (7)
Larkin, Celine
One flexible loop in OST lassos both substrates.
Runx2 protein expression utilizes the Runx2 P1 promoter to establish osteoprogenitor cell number for normal bone formation.
Mannose-6-Phosphate Isomerase
Treatment of dyspareunia secondary to vulvovaginal atrophy.
See All 7 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Treatment of dyspareunia secondary to vulvovaginal atrophy.
Fantasia HC. Treatment of dyspareunia secondary to vulvovaginal atrophy. Nurs Womens Health. 2014 Jun-Jul; 18(3):237-41.
View in:
PubMed
subject areas
Administration, Oral
Atrophy
Drug Interactions
Dyspareunia
Female
Humans
Selective Estrogen Receptor Modulators
Tamoxifen
Treatment Outcome
Vagina
Vulva
authors with profiles
Heidi C. Fantasia PhD, RN, WHNP-BC